DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $738,720 | -50.3% | 3,078 | -53.4% | 0.35% | -48.5% |
| Q1 2021 | $1,486,000 | -6.9% | 6,602 | -8.1% | 0.68% | -12.9% |
| Q4 2020 | $1,596,000 | +0.6% | 7,183 | -2.5% | 0.78% | -7.3% |
| Q3 2020 | $1,586,000 | +17.0% | 7,369 | -3.8% | 0.85% | +9.9% |
| Q2 2020 | $1,355,000 | +31.4% | 7,658 | +2.8% | 0.77% | +36.5% |
| Q1 2020 | $1,031,000 | -10.4% | 7,447 | -0.7% | 0.56% | +24.2% |
| Q4 2019 | $1,151,000 | +14.1% | 7,500 | +7.4% | 0.46% | +2.5% |
| Q3 2019 | $1,009,000 | +1.7% | 6,984 | +0.6% | 0.44% | +3.0% |
| Q2 2019 | $992,000 | +1.3% | 6,942 | -6.3% | 0.43% | +1.2% |
| Q1 2019 | $979,000 | +29.3% | 7,410 | +1.0% | 0.43% | +11.5% |
| Q4 2018 | $757,000 | -4.2% | 7,339 | +0.9% | 0.38% | +21.7% |
| Q3 2018 | $790,000 | +8.5% | 7,273 | -1.4% | 0.31% | +9.8% |
| Q2 2018 | $728,000 | -4.6% | 7,379 | -5.3% | 0.29% | -5.6% |
| Q1 2018 | $763,000 | +11.4% | 7,795 | +5.6% | 0.30% | +16.5% |
| Q4 2017 | $685,000 | +21.0% | 7,385 | +12.0% | 0.26% | +11.6% |
| Q3 2017 | $566,000 | +11.6% | 6,592 | +9.7% | 0.23% | +28.7% |
| Q2 2017 | $507,000 | +2.6% | 6,007 | +3.9% | 0.18% | +13.1% |
| Q1 2017 | $494,000 | +27.0% | 5,782 | +15.8% | 0.16% | +26.0% |
| Q4 2016 | $389,000 | -1.0% | 4,995 | -0.3% | 0.13% | -10.6% |
| Q3 2016 | $393,000 | -22.0% | 5,010 | +0.4% | 0.14% | -22.4% |
| Q2 2016 | $504,000 | +3.7% | 4,990 | -2.5% | 0.18% | +3.4% |
| Q1 2016 | $486,000 | +2.1% | 5,120 | -0.2% | 0.18% | +6.6% |
| Q4 2015 | $476,000 | +17.2% | 5,130 | +7.5% | 0.17% | +7.1% |
| Q3 2015 | $406,000 | +8.0% | 4,770 | +8.7% | 0.16% | +19.2% |
| Q2 2015 | $376,000 | +5.6% | 4,390 | +4.8% | 0.13% | +1.6% |
| Q1 2015 | $356,000 | +30.4% | 4,190 | +31.3% | 0.13% | +36.2% |
| Q4 2014 | $273,000 | -32.1% | 3,190 | -39.7% | 0.09% | -36.9% |
| Q3 2014 | $402,000 | +65.4% | 5,290 | +71.2% | 0.15% | +77.4% |
| Q2 2014 | $243,000 | +13.6% | 3,090 | +8.4% | 0.08% | +9.1% |
| Q1 2014 | $214,000 | -8.5% | 2,850 | -5.8% | 0.08% | -14.4% |
| Q4 2013 | $234,000 | +13.6% | 3,025 | +1.7% | 0.09% | +1.1% |
| Q3 2013 | $206,000 | – | 2,975 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |